Ublituximab in Combination With Ibrutinib Versus Ibrutinib Alone in Participants With Previously Treated High-Risk Chronic Lymphocytic Leukemia (CLL)

PHASE3CompletedINTERVENTIONAL
Enrollment

126

Participants

Timeline

Start Date

January 27, 2015

Primary Completion Date

April 1, 2020

Study Completion Date

April 1, 2020

Conditions
Chronic Lymphocytic Leukemia
Interventions
DRUG

Ublituximab

Administered as an IV infusion

DRUG

Ibrutinib

Administered orally

Trial Locations (88)

10019

TG Therapeutics Investigational Trial Site, New York

13210

TG Therapeutics Investigational Trial Site, Syracuse

17011

TG Therapeutics Investigational Trial Site, Camp Hill

19104

TG Therapeutics Investigational Trial Site, Philadelphia

19173

TG Therapeutics Investigational Trial Site, Newark

20817

TG Therapeutics Investigational Trial Site, Bethesda

21044

TG Therapeutics Investigational Trial Site, Columbia

21202

TG Therapeutics Investigational Trial Site, Baltimore

21215

TG Therapeutics Investigational Trial Site, Baltimore

21801

TG Therapeutics Investigational Trial Site, Salisbury

23230

TG Therapeutics Investigational Trial Site, Richmond

24060

TG Therapeutics Investigational Trial Site, Blacksburg

27607

TG Therapeutics Investigational Trial Site, Raleigh

27710

TG Therapeutics Investigational Trial Site, Durham

28204

TG Therapeutics Investigational Trial Site, Charlotte

29607

TG Therapeutics Investigational Trial Site, Greenville

29615

TG Therapeutics Investigational Trial Site, Greenville

30265

TG Therapeutics Investigational Trial Site, Newnan

31701

TG Therapeutics Investigational Trial Site, Albany

32504

TG Therapeutics Investigational Trial Site, Pensacola

32763

TG Therapeutics Investigational Trial Site, Orange City

33401

TG Therapeutics Investigational Trial Site, West Palm Beach

33486

TG Therapeutics Investigational Trial Site, Boca Raton

33709

TG Therapeutics Investigational Trial Site, St. Petersburg

33905

TG Therapeutics Investigational Trial Site, Fort Myers

35805

TG Therapeutics Investigational Trial Site, Huntsville

36604

TG Therapeutics Investigational Trial Site, Mobile

37203

TG Therapeutics Investigational Trial Site, Nashville

38120

TG Therapeutics Investigational Trial Site, Memphis

44106

TG Therapeutics Investigational Trial Site, Cleveland

44718

TG Therapeutics Investigational Trial Site, Canton

45242

TG Therapeutics Investigational Trial Site, Cincinnati

46237

TG Therapeutics Investigational Trial Site, Indianapolis

46804

TG Therapeutics Investigational Trial Site, Fort Wayne

48202

TG Therapeutics Investigational Trial Site, Detroit

50010

TG Therapeutics Investigational Trial Site, Ames

52403

TG Therapeutics Investigational Trial Site, Cedar Rapids

55416

TG Therapeutics Investigational Trial Site, Saint Louis Park

55433

TG Therapeutics Investigational Trial Site, Coon Rapids

57105

TG Therapeutics Investigational Trial Site, Sioux Falls

57201

TG Therapeutics Investigational Trial Site, Watertown

60153

TG Therapeutics Investigational Trial Site, Maywood

60201

TG Therapeutics Investigational Trial Site, Evanston

60714

TG Therapeutics Investigational Trial Site, Niles

61801

TG Therapeutics Investigational Trial Site, Urbana

66205

TG Therapeutics Investigational Trial Site, Westwood

68130

TG Therapeutics Investigational Trial Site, Omaha

68510

TG Therapeutics Investigational Trial Site, Lincoln

70121

TG Therapeutics Investigational Trial Site, New Orleans

70816

TG Therapeutics Investigational Trial Site, Baton Rouge

72401

TG Therapeutics Investigational Trial Site, Jonesboro

72703

TG Therapeutics Investigational Trial Site, Fayetteville

75230

TG Therapeutics Investigational Trial Site, Dallas

75702

TG Therapeutics Investigational Trial Site, Tyler

76201

TG Therapeutics Investigational Trial Site, Denton

78229

TG Therapeutics Investigational Trial Site, San Antonio

78234

TG Therapeutics Investigational Trial Site, Fort Sam Houston

78705

TG Therapeutics Investigational Trial Site, Austin

80012

TG Therapeutics Investigational Trial Site, Aurora

84403

TG Therapeutics Investigational Trial Site, Ogden

85224

TG Therapeutics Investigational Trial Site, Chandler

85710

TG Therapeutics Investigational Trial Site, Tucson

90045

TG Therapeutics Investigational Trial Site, Los Angeles

92835

TG Therapeutics Investigational Trial Site, Fullerton

93105

TG Therapeutics Investigational Trial Site, Santa Barbara

93449

TG Therapeutics Investigational Trial Site, Pismo Beach

94588

TG Therapeutics Investigational Trial Site, Pleasanton

94904

TG Therapeutics Investigational Trial Site, Greenbrae

97227

TG Therapeutics Investigational Trial Site, Portland

97477

TG Therapeutics Investigational Trial Site, Springfield

98104

TG Therapeutics Investigational Trial Site, Seattle

98683

TG Therapeutics Investigational Trial Site, Vancouver

99216

TG Therapeutics Investigational Trial Site, Spokane

06606

TG Therapeutics Investigational Trial Site, Bridgeport

06904

TG Therapeutics Investigational Trial Site, Stamford

02111

TG Therapeutics Investigational Trial Site, Boston

01199

TG Therapeutics Investigational Trial Site, Springfield

01608

TG Therapeutics Investigational Trial Site, Worcester

03756

TG Therapeutics Investigational Trial Site, Lebanon

08816

TG Therapeutics Investigational Trial Site, East Brunswick

07731

TG Therapeutics Investigational Trial Site, Howell Township

07962

TG Therapeutics Investigational Trial Site, Morristown

07444

TG Therapeutics Investigational Trial Site, Pompton Plains

08876

TG Therapeutics Investigational Trial Site, Somerville

97213-2982

TG Therapeutics Investigational Trial Site, Portland

02860

TG Therapeutics Investigational Trial Site, Pawtucket

77598-4420

TG Therapeutics Investigational Trial Site, Webster

Unknown

TG Therapeutics Investigational Trial Site, Ashkelon

All Listed Sponsors
lead

TG Therapeutics, Inc.

INDUSTRY

NCT02301156 - Ublituximab in Combination With Ibrutinib Versus Ibrutinib Alone in Participants With Previously Treated High-Risk Chronic Lymphocytic Leukemia (CLL) | Biotech Hunter | Biotech Hunter